SEC Form 4 · accession 0000930413-19-000020
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov Perlysky
Director
Period of report
Jan 3, 2019
Accepted (ET)
Jan 4, 2019 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (to acquire common stock)F1 | $2.80 | Jan 3, 2019 | A | 94,607 | A | Jan 4, 2020 | Jan 2, 2024 | Common Stock | 94,607 | 239,632 | D |
Explanation of responses
- F1The Reporting Person was granted 94,607 stock options. The options have a five-year term and shall vest in two equal annual tranches, beginning January 4, 2020.